iifl-logo

Glenmark Pharmaceuticals Ltd Historical Data

Add as a Preferred Source on Google
₹2,239.2
(0.60%)
Oct 27, 2026|09:24:55 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Historical Data

27/09/2026calendar-icon
27/10/2026calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

28-Sep-2026

2,380

2,392.52,307.32,325.760,5672,31,05,15,355.85,28,698

29-Sep-2026

2,330.4

2,441.52,2922,441.556,8083,00,70,93,026.98,39,781

30-Sep-2026

2,391

2,4102,334.72,334.760,7102,99,96,14,989.87,12,031

01-Oct-2026

2,339

2,3602,279.32,33156,1852,26,09,56,708.36,55,232

05-Oct-2026

2,325

2,340.52,273.52,29543,7341,12,57,85,455.32,45,450

06-Oct-2026

2,312.2

2,3202,277.32,31140,0351,13,33,30,062.12,77,080

07-Oct-2026

2,314.9

2,326.82,274.42,282.332,7351,14,46,24,620.82,53,725

08-Oct-2026

2,280

2,2842,181.22,192.240,0681,81,28,09,010.24,96,354

09-Oct-2026

2,207

2,2932,2032,29337,40893,51,57,012.91,44,169

12-Oct-2026

2,275

2,293.92,2522,28329,7621,57,83,43,987.23,51,938

13-Oct-2026

2,278

2,289.32,2532,265.314,63658,91,44,229.91,16,077

14-Oct-2026

2,275

2,286.42,2422,24615,94758,21,84,373.51,13,435

15-Oct-2026

2,242

2,289.52,241.22,250.521,8011,10,61,85,4572,42,055

16-Oct-2026

2,250.5

2,266.92,223.72,226.735,8581,56,03,90,967.84,38,283

19-Oct-2026

2,230.1

2,269.92,2002,210.221,29563,65,18,580.21,20,857

21-Oct-2026

2,216

2,249.82,163.12,194.137,5121,24,81,02,797.32,80,124

22-Oct-2026

2,168

2,218.82,160.32,198.536,9631,26,61,95,590.53,18,809

23-Oct-2026

2,196

2,203.82,101.62,166.651,6441,90,58,67,328.54,67,214

26-Oct-2026

2,135.6

2,2292,1332,225.846,9342,12,92,47,9434,99,063

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.